Gammagard Liquid Injection, Solution
Product Images NDC 0944-2700

Product Visual Gallery

This gallery contains 30 technical images submitted to the FDA as part of the official labeling for Gammagard Liquid (NDC 0944-2700). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remove The Protective Cap From The Vial To Expose The Center Of The Vial. Wipe The Stopper With An Alcohol Pad And Allow To Dry (Image 01)

An instructional illustration showing a hand holding a vial of medication and another hand removing the vial's cap. This likely demonstrates the initial steps for preparing an injection vial for use.*

FDA Label Image

Attach A Sterile Syringe To A Needle And Draw Air Into The Syringe Barrel Equal To The Amount Of Product To Be Withdrawn. Inject The Air Into The Vial And Withdraw The Desired Volume Of Gammagard Liquid. If Multiple Vials Are Required To Achieve The Desired Dose, Repeat This Step. (Image 02)

Illustration showing a hand holding a vial upside down with a syringe drawing liquid from it, demonstrating proper technique for preparing an injection for intravenous or subcutaneous administration.*

FDA Label Image

Select The Number Of Infusion Sites Depending On The Volume Of The Total Dose. See Administration For Recommended Maximum Volumes And Rates. Potential Sites For Infusion Include The Back Of Arms, Abdomen, Thighs, And Lower Back (see Figure Below). Ensure Sites Are At Least 2 Inches Apart; Avoid Bony Prominences. (Image 03)

An instructional illustration showing a human torso and arms from the back, with marked areas for subcutaneous injections. White grid patterns indicate common injection sites on the upper arms and mid to lower back regions.*

FDA Label Image

Cleanse The Infusion Site(s) With An Antiseptic Skin Preparation (e.g., Alcohol Pad) Using A Circular Motion Working From The Center Of The Site And Moving To The Outside. Allow To Dry. (Image 04)

An instructional illustration showing a person using an injection device to administer a subcutaneous injection into the abdomen area. The image depicts proper hand positioning and placement of the injection on the side of the abdomen, with the person's shirt partially lifted for access.*

FDA Label Image

Choose The Correct Needle Length To Assure That Gammagard Liquid Is Delivered Into The Subcutaneous Space. Grasp The Skin And Pinch At Least One Inch Of Skin Between Two Fingers. Insert Needle At A 90 Degree Angle With A Darting Motion Into The Subcutaneous Tissue. Secure The Needle. (Image 05)

An instructional illustration showing the proper technique for subcutaneous injection. It depicts a hand holding a syringe, injecting at a 90-degree angle into the skin near the abdomen of a person, which demonstrates correct administration of a subcutaneous injection.*

FDA Label Image

Prior To The Start Of Infusion, Check Each Needle For Correct Placement To Make Sure That A Blood Vessel Has Not Been Punctured. Gently Pull Back On The Attached Syringe Plunger And Monitor For Any Blood Return In The Needle Set. (Image 06)

An instructional illustration showing the preparation or administration of an injection, where a hand is holding a syringe and pressing the plunger, positioned near the abdominal area with a catheter or tubing attached, indicating a subcutaneous or intravenous injection procedure.*

FDA Label Image

Secure The Needle(s) In Place By Applying A Sterile Protective Dressing Over The Site. (Image 07)

An instructional illustration showing the administration of GAMMAGARD Liquid immune globulin infusion via a subcutaneous route. Two infusion sites on the abdomen are visible, each covered with transparent dressings and connected by tubing to an infusion pump held by a person.*

FDA Label Image

Logo (Logo)

FDA Label Image

Clean A Work Area With An Antibacterial Cleaner And Place All Gathered Items On The Clean Surface. Find A Quiet Work Area With As Few Distractions As Possible. (Image 08)

An instructional illustration showing components used in intravenous or subcutaneous immune globulin infusion administration. It features a red infusion pump, two vials of solution, tubing, syringes, alcohol wipes, a needle, a clamp, adhesive tape, and instruction leaflets, representing the setup and supplies for administering immune globulin injection.*

FDA Label Image

If Gammagard Liquid Is Received In A Bag Or Syringe, Skip To Step 7. Remove The Cap From The Vial. Wipe The Vial Stopper With An Alcohol Swab And Allow To Air Dry (at Least 30 Seconds). (Image 09)

An instructional illustration showing hands preparing a vial for use. The left image depicts one hand holding a vial, while the right image shows another hand removing a cap or seal from the top of the vial. The images suggest steps involved in vial preparation for injection.*

FDA Label Image

Remove Sterile Syringe From Package And Attach To A Sterile Needle. Pull Back On Plunger Of The Syringe To Fill It With Air, Which Should Equal The Amount Of Liquid You Will Be Taking From The Vial. Insert Needle Into The Center Of The Vial Stopper. Inject Air Into The Vial And Withdraw Gammagard Liquid Into The Syringe. (Image 10)

An instructional illustration showing a hand holding a vial and a syringe. The syringe plunger is pulled back, drawing liquid from the vial, depicting the preparation of an injection. This image is relevant to intravenous or subcutaneous medication administration.*

FDA Label Image

If Using A Syringe Driver Pump, Attach The Syringe Filled With Gammagard Liquid To The Needle Set. On A Hard Surface, Gently Push Down On The Plunger To Fill (prime) The Pump Tubing Up To The Needle Hub. This Will Ensure That No Air Is Left In The Tubing And Needle . (Image 11)

An instructional illustration showing a hand holding a syringe with an attached needle cap. The image focuses on the proper technique for handling or preparing an injection syringe, likely related to GAMMAGARD Liquid Immune Globulin Infusion (Human).*

FDA Label Image

Select The Number Of Infusion Sites Based On The Volume Of The Total Dose. It Is Recommended That You Not Inject More Than 20 mL For Children And 30 mL For Adults Into Each Infusion Site. (Image 12)

An instructional illustration showing a human torso and arms with multiple bandage placements on the upper arms and mid-back. The image likely demonstrates recommended injection sites for a subcutaneous injection.*

FDA Label Image

Clean The Infusion Site(s) With An Alcohol Swab. Allow To Dry (at Least 30 Seconds). (Image 13)

An illustration showing a person performing a subcutaneous injection in the abdominal area using a syringe and needle. The image demonstrates proper positioning for delivering an injection under the skin.*

FDA Label Image

Remove The Needle Cover. Firmly Grasp Skin And Pinch At Least One Inch Of Skin Between Two Fingers. Insert Needle With A Rapid Motion Straight Into The Skin At A 90 Degree Angle. Tape The Needle In Place. Repeat This Step For Each Infusion Site. (Image 14)

An instructional illustration showing the proper technique for subcutaneous injection. It depicts a hand holding a syringe inserted at a 90-degree angle to the skin on the abdomen area of a person, demonstrating the correct angle for administering the injection.*

FDA Label Image

Before Starting The Infusion, Check Each Needle For Correct Placement By Gently Pulling Back On The Attached Syringe Plunger And Looking For Any Blood In The Needle Tubing. If You See Any Blood, Remove And Throw Away The Needle Into The Sharps Container. Repeat Filling (priming) And Needle Insertion Steps In A Different Infusion Site With A New Needle. (Image 15)

Illustration showing a hand holding a syringe filled with liquid, with an arrow indicating injection into the abdominal area. The image depicts the process of subcutaneous injection, relevant for intravenous or subcutaneous administration routes.*

FDA Label Image

Secure The Needle(s) In Place By Putting A Sterile Clear Bandage Over The Needle. (Image 16)

An instructional illustration showing the application of two transparent adhesive patches with tubing on a person's abdomen, indicating the setup for a subcutaneous infusion likely related to intravenous or subcutaneous administration of a liquid medication.*

FDA Label Image

After The Infusion Is Complete, Remove The Needle Set By Pulling It Straight Out. Gently Press A Small Piece Of Gauze Over The Needle Site And Cover With A Protective Dressing (Image 17)

An instructional illustration showing a hand inserting a needle or catheter into the skin, with an arrow indicating the direction of insertion. The cross-section of skin layers is depicted below to demonstrate proper subcutaneous or intravenous administration technique.*

FDA Label Image

Principal Display Panel (10 mL Bottle Label)

Label for GAMMAGARD Liquid 10% (Immune Globulin Infusion (Human)) Injection solution, 100 mg/mL strength. The label indicates it is for intravenous or subcutaneous use, supplied as a 10 mL single-dose container with 1 g total. Manufactured by Takeda Pharmaceuticals America, Inc. and labeled by Baxalta US Inc., Lexington, MA. The label includes storage instructions and a barcode.*

FDA Label Image

Principal Display Panel (10 mL Bottle Carton)

Packaging label for GAMMAGARD Liquid 1g/10mL Immune Globulin Infusion (Human) 10% injection solution. The label indicates it is for intravenous or subcutaneous administration and includes storage instructions and manufacturer information, Takeda Pharmaceuticals America, Inc., under the Shire brand.*

FDA Label Image

Principal Display Panel (25 mL Bottle Label)

GAMMAGARD Liquid 100 mg/mL injection solution for intravenous or subcutaneous infusion. The single-dose container label shows 2.5 g in 25 mL and is manufactured by Baxalta US Inc., a Takeda Pharmaceutical company. The label includes the NDC 0944-2700-09 and states it is not made with natural rubber latex.*

FDA Label Image

Principal Display Panel (25 mL Bottle Carton)

Packaging label for GAMMAGARD Liquid Immune Globulin Infusion (Human) 10% injection solution, 2.5g per 25mL single-dose container. The label shows the product name, strength, dosage form for intravenous or subcutaneous infusion, storage instructions, manufacturer (Shire, a subsidiary of Takeda Pharmaceuticals), and contact information. The design includes blue and orange diagonal stripes on a white background.*

FDA Label Image

Principal Display Panel (50 mL Bottle Label)

GAMMAGARD Liquid 10% Immune Globulin Infusion (Human) injection solution label showing 5g per 50mL single-dose container. The label indicates use for intravenous or subcutaneous administration, storage requirements between 2-8°C, and room temperature up to 25°C. Manufactured by Takeda Pharmaceuticals America, Inc., with U.S. license information and Shire branding also visible.*

FDA Label Image

Principal Display Panel (50 mL Bottle Carton)

The image shows a packaging label for GAMMAGARD Liquid Immune Globulin Infusion (Human) 10%, 5g per 50mL injection solution. It is indicated for intravenous or subcutaneous administration, supplied in single-dose containers. The label includes manufacturer details for Takeda Pharmaceuticals America, Inc., storage instructions, and additional product information such as absence of preservatives and stabilizer use.*

FDA Label Image

Principal Display Panel (100 mL Bottle Label)

GAMMAGARD Liquid 10% Immune Globulin Infusion (Human) injection solution 10 g/100 mL single-dose container. The label specifies intravenous or subcutaneous administration, storage conditions (2°C to 8°C, do not freeze), and room temperature (up to 25°C). Manufactured by Baxalta US Inc., Lexington, MA, under Takeda Pharmaceuticals America, Inc. The label features NDC 0944-2700-11 and includes cautionary information regarding latex.*

FDA Label Image

Principal Display Panel (100 mL Bottle Carton)

GAMMAGARD Liquid Immune Globulin Infusion (Human) 10% 10g/100mL injection solution packaging label. The label states the product is for intravenous or subcutaneous administration and contains 10g of Immune Globulin (Human) per 100mL. Manufactured by Takeda Pharmaceuticals America, Inc. under the Shire brand, with storage instructions included.*

FDA Label Image

Principal Display Panel (200 mL Bottle Label)

Label for GAMMAGARD Liquid 10% Immune Globulin Infusion (Human) injection solution, 20 g/200 mL single-dose container. The infusion is for intravenous or subcutaneous use. Manufactured by Baxalta US Inc., a Takeda company, Lexington, MA. Storage instructions include refrigeration at 2°-8°C and avoiding freezing; room temperature storage permitted up to 25°C.*

FDA Label Image

Principal Display Panel (200 mL Bottle Carton)

Packaging label for GAMMAGARD Liquid Immune Globulin Infusion (Human) 10% injection solution, 20g/200mL, by Takeda Pharmaceuticals America, Inc. Label states intravenous or subcutaneous administration. Highlights single-dose container and important storage instructions with trademarks of Shire and Baxalta. Product NDC 0944-2700-06 visible.*

FDA Label Image

Principal Display Panel (300 mL Bottle Label)

GAMMAGARD Liquid 100 mg/mL Immune Globulin Infusion (Human) injection solution label for intravenous and subcutaneous administration. The label shows the product strength, 30g per 300mL single-dose container, with storage instructions and manufacturer information for Baxalta US Inc., Lexington, MA.*

FDA Label Image

Principal Display Panel (300 mL Bottle Carton)

GAMMAGARD Liquid 10% Immune Globulin Infusion (Human) 30g/300mL injection solution packaging label. The product is for intravenous and subcutaneous administration, supplied as a single-dose container. Manufactured by Takeda Pharmaceuticals America, Inc., it includes storage instructions and cautions such as refrigeration at 2-8°C and no natural rubber latex. The label features the Shire logo and indicates U.S. licensing.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.